Myeloproliferative, myelodysplastic and aplastic anaemia Flashcards

(47 cards)

1
Q

Haemopoesis Definition

A

The production of blood cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where does haemopoesis occur in the foetus?

A

0-2 months - yolk sac
2-7 months - liver, spleen
5-9 months - bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where does haemopoesis occur in infants

A

Bone marrow - all bones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where does haemopoesis occur in adults

A

Bone marrow

vertebrae, ribs, sternum, skull, sacrum, pelvis, ends of femur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Haemopoesis hierarchy

A

DRAW

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pluriopotent stem cell

A

Numbers diminish with age, committed to divide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Colony forming unit

A

commited to divide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where are haemopoetic stem cells found?

A

BM
Peripheral blood after treatment with G-CSF
Umbillical cord blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Haempoetic stem cell characteristics

A
  • self renewal
  • unspecialised
  • ability to differentiate (mature)
  • quescent (non in cell cycle)
  • rare cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Control of stem cell fate

A

HSC can

a. undergo self-renewal (identical copy)
b. Apoptosis (programmed cell death)
c. Differentations (Matureation and specialisation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Types of stem cell division

A

Types of division

Symmetrical - both daughter cells mature leading to a contraction in stem cell numbers

Assymetrical division- one new daughter cell (maintenance of numbers), one differentiations

Symmetrical stem cell - Expansion
of stem cell number

Balance is influencced by complex interplay of micro-environment (the niche) and internal ques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Stroma definition

A

BM microenviroment that supports the developing haemopoetic stem cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Stroma/ bone marrow microenvironment features

A

Stromal cells + ECM

Stromal cells - macrophages, fibroblasts, endothelial cells, fat cells, reticulum cells

Surrounded by ECM
-laminin, fibronectin, collagen, Proteoglycans

Sinusoids: network of BVs lined by a singel layer of endothelial cells, support haemopoetic cells, allow passage of newly formed cells into the circulation

Haemopoetic cords/islands
- site of haemopoesis

Macrophages

  • found within haemopoetic cords
  • contain stored iron (haemosiderrin + ferritin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pre-malignant and malignant conditions are termed clonal because..?

A

They arise from a single ancestral cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Examples

A
  1. over-production = Myeloproliferative disorder
  2. Under production = Aplastic anaemia (e.g fanconis)
  3. Abnormal cells produced
    = myelodysplasia, leukaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Myeloproliferative disorders

A

Polycythaemia rubra vera
Essential thrombocytosis
Myelofibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Myeloproliferative disorders definition

A

Uncontrolled proliferation of one or more of the myeloid stem cell line. While the cells proliferate the also retain the ability to differntiate into RBCs, WBCs or platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Myelofibrosis definition

A

Marrow scarring due to hyperplasia of megakarocytes which causes increased production of PDGF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Causes of myelofibrosis

A

50% JAK2, 50% calreticulin

Increased PDGF leads to myeloid metaplasia

Massive hepatomegaly

20
Q

Presentation of myelofibrosis

A

constitutional symptoms

Abdominal discomfort - massive spleenn

BM failure (Anaemia, Infection, bleeding)

21
Q

Investigations of myelofibrosis

A

BM

  • aspirate- dry
  • trephone - shows fibrosis

FBC

  • pts in high then thrombocytopenia
  • decreased RBC
  • WCC increased or decreased

Blood fillm

  • tear drops RBCs
  • leucoerythroblastic cells
22
Q

Treatment of myelofibrosis

A

Under 50
- myeloblative SCT

50-65
- non-myeloblative BMT

23
Q

Prognosis of myelofibrosis

A

can be curative with transplant

24
Q

Essential thrombocytosis definition

A

Clonal proliferation of megakaryocytes leads to increased platelets (thrombocytosis) with impaired function

Pt >600x 10 9 peristently

25
Cause of Essential thrombocytosis
50% calreticulin mutation | 50% JAK2
26
Clinical features of essential thrombocytosis
microvascular occlusion - headaches - dizziness - erythomegaly - splenomegaly - thombosis - bleeding
27
Investigations of essential thrombocytosis
exclude other causes (bleeding, infection, malignancy) FBC (+ repeat) Pt >600 x109 persistently ESR, CRP, Fibrinogen
28
Treatment of essential thrombocytosis
Stratification into risk groups Low risk - (60 - one or more high risk features plt >1500 x109/l previous thrombosis or thrombotic risk factors e.g diabetes or hypertension
29
Polycythaemia rubra vera definition
increase in RBC volume due to a clonal malignancy of a marrow stem cell
30
Causes of Polycythaemia rubra vera
Jak2 mutation is present in more than 90%
31
Clinical features of Polycythaemia rubra vera
due to hyperviscosity and hypervolaemia - headaches - dizziness - visual disturbances - tinnitus - pruritis (after hot bath) - erythromyalgia - gout (increased urate) - plerothic complexion - splenomegaly - thrombosis - haemorrhage
32
Investigations of Polycythaemia rubra vera
``` bloods -increased RCC -increased packed cell volume - increased Hb Blood film JAK2 mut Serum ferritin ```
33
Management of Polycythaemia rubra vera
``` no cure venesection low dose aspirin -cytotoxic drugs e.g hydroxycarbamine if symptomatic -splenomegaly - radioactive phosphorus ```
34
Prognosis of Polycythaemia rubra vera
Most remain well | -thrombosis/ haemorrhage main complocation
35
Classification of myeloproliferative disorders based on the cell type
RBC - polycythaemia rubra vera WBC - chronic myeloid leukaemia Platelets - Essential thrombocytopenia Fibroblasts - myelofibrosis
36
High risk ET treatment
First line = apsirin + hydroxycarbamide (ribonucelotide reductase inhibitor resulting in reduced production of deoxyribonucleotides Second line therapy = anagrelide + aspiring - inhibits megakaryocyte differentiation Inf-a useful in management of ET in pregnancy JAK2 inhbitrs e.g ruxoltinib
37
JAK 2 inhibitors mechanism of action
JACK2 mutations result in continuous activatio of JAK receptor regardless of ligand binding Specifically ruxotilinib Inhibits JAK1 and 2 -70% of pts reduuced splenomegaly and functional improvement
38
Myelodysplastic syndrome (MDS) definition
Dysplasia and ineffective haemooesis in >1 o the myeloid series (RBC, Pts, Neutrophils)
39
Features of Myelodysplastic syndrome (MDS)
Common in elderly 25% transform to AML de novo or secondary to previous chemo/rx associated with acquired cytogenetic abnormalities
40
CFs Myelodysplastic syndrome (MDS)
20% present with infections | 70-80% present with fatigue due to anaemia
41
Management of Myelodysplastic syndrome (MDS)
Depends on age of patient - supportive care- blood and plt transfusion - Growth factors - erythropoetin + granucolcyte colony stimulating factor (not much success as stimulating cells produces more dysplastic cells) - Low dose chemo e.g hydroxycarbamide, low dose cytarabine - immunosuppression - high dose chemo - only in selected patients (AML-type) - Allogenic stem cell transplantation only in selevted patients
42
Types of Myelodysplastic syndromes (MDS)
Multiple sub-types based on morphology and % blasts 1. refractory anaemia or 2. refractory anaemia with sideroblasts (perinuclear ring of iron granules) 3. refractory anaemia with excessive blasts
43
Fanconis anaemia features
10-20% of aplastic anaemia cases Autosomal recessive inheritance BONE MARROW FAILURE
44
Fanconis anaemia characteristics
- somatic abnormalites - bone marrow failure - short telomeres - malignancy - chromosome instability
45
Types of Fanconis anaemia
7 genetic FANCA to FANC-G
46
Clinical features of Fanconis anaemia
``` micropthalmia GU malformations GI malformations mental retardation Hearing loss CNS e.g hydrocephalus ```
47
Treatment of Fanconis anaemia
``` Gold standard- allogenc stem cell transplant Other options are: -supportive care -corticosteroids -androgens ``` Life time surveillance for secondary tumours